GNTA Genenta Science S.p.A. NASDAQ · United States

Genenta Science S.p.A. (GNTA) news

Genenta Science S.p.A. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker GNTA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Genenta Science S.p.A. news

We have not published a story on Genenta Science S.p.A. yet. When there is news, it will appear here.

Genenta Science S.p.A. annual financials

Line	FY2025	FY2024
Research and development	€2.7 million	€4.8 million
Net income (loss)	-€6.5 million	-€8.9 million
Cash from operations	-€6.9 million	-€6.2 million
Short-term investments	€22.6 million	€8.1 million

Latest balance sheet, Dec 31, 2021 (20-F): cash and equivalents $25.7 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Genenta Science S.p.A.

What is the ticker symbol of Genenta Science S.p.A.?

Genenta Science S.p.A. trades under the ticker GNTA on NASDAQ.

Where is Genenta Science S.p.A. listed?

Genenta Science S.p.A. is listed on NASDAQ.

Which country or territory is Genenta Science S.p.A. listed under?

Our directory records Genenta Science S.p.A. under United States.

Does aibio.space cover Genenta Science S.p.A.?

aibio.space lists Genenta Science S.p.A. among 2,820 public biotech companies and publishes its news here as stories appear.

How much cash does Genenta Science S.p.A. have?

$25.7 million in cash at Dec 31, 2021, per its 20-F.

Investor discussion: Genenta Science S.p.A.

Members talk about Genenta Science S.p.A. (GNTA). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Genenta Science S.p.A., newest first. Each line links the filing it comes from.

Oct 21, 2026Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source
Jul 31, 2026Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source
Jul 1, 2026Listings
Reported a reverse stock split. SEC Form 6-K. Source
Jun 17, 2026Listings
Reported a reverse stock split. SEC Form 6-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:GNTA on TradingView.

Listing details

Company: Genenta Science S.p.A.
Ticker: GNTA
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction